Pharma marries VCs to give birth to Biotechs
Authored by Karl Simpson A marriage made of true love or one of convenience. Whichever, these consummations between pharma and venture capitalists are increasingly frequent and in recent weeks we’ve...
View ArticleDRI Capital raises third fund for royalty investments
Authored by Karl Simpson Royalties for pharmaceutical and biotech products is a constant feature of the way in which programmes get funded and investors get a return. The opportunity to cash in on a...
View ArticleLiftstream marks 10th anniversary
Authored by Karl Simpson January 2014 was a key month at Liftstream HQ. On the 7th January, Liftstream reached a key milestone in its existence, a full 10 years since our incorporation. It was a great...
View ArticleDr Michael Pellini – Foundation Medicine – Executive Leadership Series
Authored by Karl Simpson At the beginning of 2013 Liftstream profiled 13 life science leaders we believed were going to make an impact over the course of the year. Below we outline how Dr Michael...
View ArticleHow can biotech enhance executive leadership?
Take our short survey and participate in a global gender diversity study Working in biotech, pharma or venture capital? – Board-level directors and investors – Entry level, through...
View ArticleBiotechnology must embrace a more diverse future of leadership
Authored by Karl Simpson When you talk to biotech entrepreneurs and sector investors, the topic of management and leadership is one that often features very strongly as the critical success factor....
View ArticleClik here to view.
Biopharma Bucking the Trend for Separating Board Chair and CEO
Read the full article... The post Biopharma Bucking the Trend for Separating Board Chair and CEO appeared first on Liftstream.
View Article
